PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-157

  1. 1,316 Posts.
    lightbulb Created with Sketch. 263
    The FDA have just approved iPPS in its injectable form for the retired NFL player trial. That fact is already a big win. The steps taken to get that initial trial approval isn't a walk in the park, so it's a positive foot in the door for mine.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.005(2.17%)
Mkt cap ! $82.20M
Open High Low Value Volume
23.5¢ 23.5¢ 23.0¢ $85.35K 365.1K

Buyers (Bids)

No. Vol. Price($)
10 280011 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 44703 3
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.